-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Prime Medicine, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to Q3 2025.
- Prime Medicine, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was $3.39M, a 97.8% increase year-over-year.
- Prime Medicine, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was $6.63M, a 5.88% decline year-over-year.
- Prime Medicine, Inc. annual Nonoperating Income (Expense) for 2024 was $6.59M, a 3.21% increase from 2023.
- Prime Medicine, Inc. annual Nonoperating Income (Expense) for 2023 was $6.38M.
- Prime Medicine, Inc. annual Nonoperating Income (Expense) for 2022 was -$6.23M, a 92.4% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)